UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

The New England journal of medicine, 2018-03, Vol.378 (13), p.1211-1223

2018

Volltextzugriff (PDF)

Bacterial Biofilm Infection Detected in Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Plastic and reconstructive surgery (1963), 2016-06, Vol.137 (6), p.1659-1669

2016

Volltextzugriff (PDF)

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

Haematologica (Roma), 2016-09, Vol.101 (9), p.e387

2016

Volltextzugriff (PDF)

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Clinical cancer research, 2008-08, Vol.14 (16), p.5198-5208

2008

Volltextzugriff (PDF)

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2009-11, Vol.27 (32), p.5410-5417

2009

Volltextzugriff (PDF)

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma

Oncotarget, 2018-11, Vol.9 (90), p.36126-36136

2018

Volltextzugriff (PDF)

Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer

PloS one, 2017-09, Vol.12 (9), p.e0183891-e0183891

2017

Volltextzugriff (PDF)

SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-05, Vol.24 (3), p.589-601

2021

Volltextzugriff (PDF)

CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia

BMC gastroenterology, 2022-04, Vol.22 (1), p.197-197, Article 197

2022

Volltextzugriff (PDF)

A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response

Clinical cancer research, 2014-05, Vol.20 (10), p.2761-2772

2014

Volltextzugriff (PDF)

The efficacy of methotrexate for lymphomatoid papulosis

Journal of the American Academy of Dermatology, 2015-06, Vol.72 (6), p.1088-1090

2015

Volltextzugriff (PDF)

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

Clinical cancer research, 2009-02, Vol.15 (4), p.1417-1427

2009

Volltextzugriff (PDF)

Update and new approaches in the treatment of Castleman disease

Journal of Blood Medicine, 2016-01, Vol.7, p.145-158

2016

Volltextzugriff (PDF)

Erdheim-Chester disease harboring the BRAF V600E mutation

Journal of clinical oncology, 2012-11, Vol.30 (32), p.e331-e332

2012

Volltextzugriff (PDF)

Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity

Haematologica (Roma), 2010-11, Vol.95 (11), p.1977-1979

2010

Volltextzugriff (PDF)

Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

International journal of molecular sciences, 2018-06, Vol.19 (6), p.1758

2018

Volltextzugriff (PDF)

Defining double-hit lymphoma in the clinic

Blood, 2021-04, Vol.137 (16), p.2132-2133

2021

Volltextzugriff (PDF)

Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e003744

2022

Volltextzugriff (PDF)

Increasing rates of SSA/P detection in a large open-access Australian colonoscopy cohort

Endoscopy International Open, 2019-03, Vol.7 (3), p.E310-E316

2019

Volltextzugriff (PDF)

Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient

International journal of hematology, 2010-03, Vol.91 (2), p.347-348

2010

Volltextzugriff (PDF)

Assessment of hypertension service availability in some primary health centres in Nigeria: a mixed-methods study

BMJ open, 2023-08, Vol.13 (8), p.e073833-e073833

2023

Volltextzugriff (PDF)

Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol

Journal of the American Academy of Dermatology, 2008-10, Vol.59 (4), p.589-595

2008

Volltextzugriff (PDF)

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Blood, 2015-01, Vol.125 (1), p.71-81

2015

Volltextzugriff (PDF)

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder

Radiotherapy and oncology, 2023-01, Vol.178, p.109430, Article 109430

2023

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(80)
Berichte
(8)

Sprache

Englisch
(88)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

Bacterial Biofilm Infection Detected in Breast Implant–Associated Anaplastic Large-Cell Lymphoma

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma

Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer

SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence

CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia

A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response

The efficacy of methotrexate for lymphomatoid papulosis

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

Update and new approaches in the treatment of Castleman disease

Erdheim-Chester disease harboring the BRAF V600E mutation

Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity

Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

Defining double-hit lymphoma in the clinic

Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes

Increasing rates of SSA/P detection in a large open-access Australian colonoscopy cohort

Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient

Assessment of hypertension service availability in some primary health centres in Nigeria: a mixed-methods study

Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol

Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy

Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma

Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder

Suchergebnisse filtern